Abstract

The production of cultured red blood cells (cRBC) for transfusion purposes requires large scale cultures and downstream processes to purify enucleated cRBC. The membrane composition, and cholesterol content in particular, are important during proliferation of (pro)erythroblasts and for cRBC quality. Therefore, we tested the requirement for cholesterol in the culture medium during expansion and differentiation of erythroid cultures with respect to proliferation, enucleation and purification by filtration. The low cholesterol level (22 µg/dl) in serum free medium was sufficient to expand (pro)erythroblast cultures. Addition of 2.0 or 5.0 mg/dL of free cholesterol at the start of differentiation induction inhibited enucleation compared to the default condition containing 3.3 mg/dl total cholesterol derived from the addition of Omniplasma to serum free medium. Addition of 5.0 mg/dl cholesterol at day 5 of differentiation did not affect the enucleation process but significantly increased recovery of enucleated cRBC following filtration over leukodepletion filters. The addition of cholesterol at day 5 increased the osmotic resistance of cRBC. In conclusion, cholesterol supplementation after the onset of enucleation improved the robustness of cRBC and increased the yield of enucleated cRBC in the purification process.

Details

Title
Production and stability of cultured red blood cells depends on the concentration of cholesterol in culture medium
Author
Claessen, M. J. A. G. 1 ; Yagci, N. 2 ; Fu, K. 2 ; Brandsma, E. 3 ; Kersten, M. J. 4 ; von Lindern, M. 2 ; van den Akker, E. 2 

 Sanquin Blood Supply, Department Research, Amsterdam, The Netherlands (GRID:grid.417732.4) (ISNI:0000 0001 2234 6887); Amsterdam University Medical Centers, Cancer Center Amsterdam, Department of Hematology, Amsterdam, The Netherlands (GRID:grid.16872.3a) (ISNI:0000 0004 0435 165X); Amsterdam University Medical Center, Landsteiner Laboratory, Amsterdam, The Netherlands (GRID:grid.509540.d) (ISNI:0000 0004 6880 3010) 
 Sanquin Blood Supply, Department Research, Amsterdam, The Netherlands (GRID:grid.417732.4) (ISNI:0000 0001 2234 6887); Amsterdam University Medical Center, Landsteiner Laboratory, Amsterdam, The Netherlands (GRID:grid.509540.d) (ISNI:0000 0004 6880 3010) 
 Sanquin Blood Supply, Department Research, Amsterdam, The Netherlands (GRID:grid.417732.4) (ISNI:0000 0001 2234 6887); Saxion University of Applied Sciences, Department of Life Sciences, Enschede, The Netherlands (GRID:grid.29742.3a) (ISNI:0000 0004 5898 1171) 
 Amsterdam University Medical Centers, Cancer Center Amsterdam, Department of Hematology, Amsterdam, The Netherlands (GRID:grid.16872.3a) (ISNI:0000 0004 0435 165X) 
Pages
15592
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3076304012
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.